HANSARD
Respiratory Syncytial Virus Vaccine Eligibility Criteria
- 3:35 pm
- People with respiratory illnesses, such as my constituent Jane Wessman, benefit greatly from receiving the free respiratory syncytial virus vaccine and also the shingles vaccine. The arbitrary decision to end eligibility for these vaccines at the age of 80 has a profound effect on those who need it the most. Accordingly, my constituent and others would like to see the age barrier lifted and the vaccines continuing to be available after the age of 80.The petition states:“The petitioners therefore request that the Government take into account the concerns of the petitioners and take immediate action to seek a reallocation of funds to ensure that the provision of the free Respiratory Syncytial Virus vaccine dose and Shingles vaccine dose is extended to those individuals who are 80 years of age or older.”Following is the full text of the petition:[The petition of residents of the United Kingdom,Declares that extending the eligibility criteria for the free Respiratory Syncytial Virus vaccine and the Shingles vaccine dose to individuals who are 80 years of age or older would bring considerable health benefits; notes that the former illness can cause acute respiratory infection, influenza-like illness, community-acquired pneumonia and lead to death and the latter illness can caused decreased vision or permanent blindness; and notes that vaccine doses for the Respiratory Syncytial Virus and Shingles virus are recommended to all individuals 80 years of age and over in the United States of America and in the European Union.The petitioners therefore request that the House of Commons urge the Government to take into account the concerns of the petitioners and take immediate action to seek a reallocation of funds to ensure that the provision of the free Respiratory Syncytial Virus vaccine dose and Shingles vaccine dose is extended to those individuals who are 80 years of age or older.And the petitioners remain, etc.][P003045]